GenBody COVID-19 Ag Test
SARS-CoV-2 Infection
ApprovedActive
Key Facts
About GenBody
GenBody is a private diagnostics company headquartered in San Diego, specializing in rapid tests for infectious diseases. It achieved commercial stage with its FDA EUA-authorized COVID-19 antigen test, which was selected by the NIH's Rapid Acceleration of Diagnostics (RADx) initiative for US production, indicating government validation. The company operates a direct manufacturing and distribution model, targeting distributors, testing sites, and CLIA labs with scalable packaging options. Its immediate focus is capitalizing on its COVID-19 test while navigating a post-pandemic market and potential platform expansion.
View full company profileTherapeutic Areas
Other SARS-CoV-2 Infection Drugs
| Drug | Company | Phase |
|---|---|---|
| Talis One COVID-19 Test | Talis Biomedical | Commercial (EUA) |
| Logix Smart COVID-19 Test | Co-Diagnostics | Commercial |
| COV19 qcLAMP Kit | BIOPIX-T | Approved |
| CovidDetect | Prime Discoveries | Commercial |
| FabenCOV® (e-FabRIC) | Fabentech | Phase 2 |
| Favipiravir | Viriom | Bioequivalence |
| EDP-323 | Enanta Pharmaceuticals | Phase 1 |
| InteliSwab® COVID-19 Rapid Antigen Test | OraSure Technologies | Approved |